These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16375697)

  • 21. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the STAT pathway in head and neck cancer: recent advances and future prospects.
    Nikitakis NG; Siavash H; Sauk JJ
    Curr Cancer Drug Targets; 2004 Dec; 4(8):637-51. PubMed ID: 15578920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells.
    Chien CM; Yang SH; Lin KL; Chen YL; Chang LS; Lin SR
    Chem Biol Interact; 2008 Oct; 176(1):40-7. PubMed ID: 18638462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.
    Kim C; Baek SH; Um JY; Shim BS; Ahn KS
    BMC Nephrol; 2016 Feb; 17():19. PubMed ID: 26911335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
    Cooper JC; Boustead JN; Yu CL
    Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
    Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
    J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
    Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.
    Recio C; Guerra B; Guerra-Rodríguez M; Aranda-Tavío H; Martín-Rodríguez P; de Mirecki-Garrido M; Brito-Casillas Y; García-Castellano JM; Estévez-Braun A; Fernández-Pérez L
    Oncogene; 2019 Jun; 38(24):4657-4668. PubMed ID: 30783189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 suppresses cytokine induced, Stat5 mediated activation of transcription.
    Fritsche M; Mundt M; Merkle C; Jähne R; Groner B
    Mol Cell Endocrinol; 1998 Aug; 143(1-2):143-54. PubMed ID: 9806359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lineage-Specific and Non-specific Cytokine-Sensing Genes Respond Differentially to the Master Regulator STAT5.
    Zeng X; Willi M; Shin HY; Hennighausen L; Wang C
    Cell Rep; 2016 Dec; 17(12):3333-3346. PubMed ID: 28009300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.
    Desrivières S; Kunz C; Barash I; Vafaizadeh V; Borghouts C; Groner B
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):75-87. PubMed ID: 16947086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
    Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
    Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells.
    Linher-Melville K; Singh G
    Mol Cell Endocrinol; 2017 Aug; 451():40-52. PubMed ID: 28202313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias.
    Juen L; Brachet-Botineau M; Parmenon C; Bourgeais J; Hérault O; Gouilleux F; Viaud-Massuard MC; Prié G
    J Med Chem; 2017 Jul; 60(14):6119-6136. PubMed ID: 28654259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
    Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T
    Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An invertebrate signal transducer and activator of transcription 5 (STAT5) ortholog from the disk abalone, Haliotis discus discus: Genomic structure, early developmental expression, and immune responses to bacterial and viral stresses.
    Bathige SD; Umasuthan N; Park HC; Lee J
    Dev Comp Immunol; 2016 Mar; 56():46-56. PubMed ID: 26616564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal effects of STAT5 and STAT3 in breast cancer.
    Walker SR; Nelson EA; Zou L; Chaudhury M; Signoretti S; Richardson A; Frank DA
    Mol Cancer Res; 2009 Jun; 7(6):966-76. PubMed ID: 19491198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign.
    Binder C; Lafayette A; Archibeque I; Sun Y; Plewa C; Sinclair A; Emkey R
    Assay Drug Dev Technol; 2008 Feb; 6(1):27-37. PubMed ID: 18336085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.